clinical trials

Sylentis' dry eye drug misses primary goals in phase 3
Sylentis' dry eye drug misses primary goals in phase 3
Fierce Biotech
Sylentis
dry eye disease
PharmaMar
siRNA
tivanisiran
clinical trials
Flag link:
First phase 3 data back Scynexis' new-class antifungal
First phase 3 data back Scynexis' new-class antifungal
Fierce Biotech
Scynexis
ibrexafungerp
antifungals
clinical trials
Flag link:
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Roche
Alzheimer's disease
clinical trials
AC Immune
crenezumab
Biogen
aducanumab
Flag link:
Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial
Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial
Pharmaceutical Business Review
Pfizer
Eli Lilly
tanezumab
clinical trials
osteoarthritis pain
osteoarthritis
Flag link:
FDA opens doors for digital tools to facilitate siteless trials, find new endpoints
FDA opens doors for digital tools to facilitate siteless trials, find new endpoints
BioCentury
FDA
digital pharma
clinical trials
siteless trials
artificial intelligence
Flag link:
Alexion’s newly approved rare-disease drug notches another clinical trial win
Alexion’s newly approved rare-disease drug notches another clinical trial win
Stat
Alexion Pharmaceuticals
clinical trials
Ultomiris
kidney disease
PNH
Flag link:
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Pharmaceutical Business Review
Ironwood Pharmaceuticals
IW-6463
CNS disorders
clinical trials
Flag link:
Advaxis suffers another blow as FDA puts phase 3 on partial hold
Advaxis suffers another blow as FDA puts phase 3 on partial hold
Fierce Biotech
Advaxis
vaccines
FDA
clinical trials
axalimogene filolisbac
cervical cancer
Flag link:
What’s up with all the buzz about Gilead’s PhIII NASH drug selonsertib?
What’s up with all the buzz about Gilead’s PhIII NASH drug selonsertib?
Endpoints
clinical trials
NASH
Gilead Sciences
selonsertib
Flag link:
Redx gets regulatory nod to restart RXC004 clinical trial
Redx gets regulatory nod to restart RXC004 clinical trial
Pharmaceutical Business Review
Redx
MHRA
RXC004
clinical trials
solid tumors
Flag link:
Sorrento shows fast, durable arthritis pain relief with ‘spicy’ injection in early study
Sorrento shows fast, durable arthritis pain relief with ‘spicy’ injection in early study
Fierce Biotech
Sorrento Therapeutics
osteoarthritis of the knee
clinical trials
Resiniferatoxin
capsaicin
Flag link:
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Fierce Pharma
AbbVie
JNJ
Imbruvica
pancreatic cancer
clinical trials
Flag link:
How to stop a lack of diversity undermining clinical trial data
How to stop a lack of diversity undermining clinical trial data
Financial Times
clinical trials
race
ethnicity
HIV
hypertension
cancer
Flag link:
AbbVie's Imbruvica misses pancreatic cancer endpoints
AbbVie's Imbruvica misses pancreatic cancer endpoints
BioCentury
AbbVie
Imbruvica
clinical trials
PCYC-1137
metastatic pancreatic cancer
Flag link:
ADC doses first patient in phase I trial of ADCT-601 in advanced solid tumors
ADC doses first patient in phase I trial of ADCT-601 in advanced solid tumors
Pharmaceutical Business Review
ADC Therapeutics
oncology
ADCT-601
solid tumors
clinical trials
Flag link:
On heels of Loxo buy, Lartruvo setback deals a blow to Lilly's oncology hopes
On heels of Loxo buy, Lartruvo setback deals a blow to Lilly's oncology hopes
Fierce Pharma
Eli Lilly
Lartruvo
soft tissue sarcoma
clinical trials
Flag link:
Lipocine talks up interim data from small NASH study
Lipocine talks up interim data from small NASH study
Fierce Biotech
Lipocine
NASH
LPCN 1144
clinical trials
Flag link:
Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
Endpoints
Alzheon
IPOs
clinical trials
ALZ-801
Alzheimer's disease
Flag link:
Zafgen has something to cheer as diabetes drug makes the cut in PhII study, quelling cardio safety fears
Zafgen has something to cheer as diabetes drug makes the cut in PhII study, quelling cardio safety fears
Endpoints
Zafgen
diabetes
clinical trials
ZGN-1061
Flag link:
Aptinyx stung by pain drug's mid-stage miss
Aptinyx stung by pain drug's mid-stage miss
BioPharma Dive
Aptinyx
diabetic peripheral neuropathy
clinical trials
NYX-2925
Flag link:

Pages